Posts Tagged 'Matinas BioPharma Holdings Inc.'

On Tuesday, well before the opening bell, Matinas BioPharma Holdings, Inc. (OTCQB: MTNB), a clinical-stage biopharmaceutical, announced that the U.S. Food and Drug Administration (FDA) designated the Company’s lead drug candidate, MAT2203, as a Qualified Infectious Disease Product (QIDP) with Fast Track status.  Had they been listed on the NASDAQ exchange, shares of MTNB stock would have exploded like Amarin ...